Related Experiment Videos

Limitations of randomized clinical trials in chronic diseases: explanations and recommendations

Theodore Pincus¹

¹Division of Rheumatology and Immunology at Vanderbilt University Medical Center, Nashville, Tenn., USA.

Advances in Mind-Body Medicine

|March 13, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Screening for Anxiety, Depression, and Fibromyalgia in Routine Care of All Rheumatic Diagnoses on a Multidimensional Health Assessment Questionnaire (MDHAQ).

The Journal of rheumatology·2026

Similar Pain Scores in Rheumatoid Arthritis and Osteoarthritis Over 45 Years Despite Dramatically Fewer Swollen Joints in Rheumatoid Arthritis: Are Scores Based as Much on Pain Sensitization and Patient Distress as on Inflammation and/or Structural Damage?

ACR open rheumatology·2026

Should Joint Deformity, which is More Common Than Swelling or Tenderness, be Assessed in all Rheumatoid Arthritis Patients and Databases?

ACR open rheumatology·2025

Elevated DAS28, CDAI, RAPID3 and five of seven RA core data set measures in patients with positive screens for anxiety, depression or fibromyalgia on an MDHAQ.

Rheumatology (Oxford, England)·2025

RheuMetric Physician 0 to 10 Estimates of Inflammation, Damage, and Patient Distress at Initial Versus Follow-Up Visits in Contemporary Rheumatology Care.

ACR open rheumatology·2025

Interrater reliability of RheuMetric checklist scales for physician global assessment, inflammation, damage and patient distress.

Rheumatology advances in practice·2024

See all related articles